2022

1. Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase-2 inhibitor and toceranib phosphate

   Veterinary and Comparative Oncology, Vol. 20, Núm. 1, pp. 179-188